Atezolizumab for advanced alveolar soft part sarcoma

Authors

Alice P Chen, National Cancer Institute
Brian A Van Tine, Washington University School of Medicine in St. Louis
et al.

Journal

New England Journal of Medicine

Publication Date

9-7-2023

Volume

389

Issue

10

First Page

911

Last Page

921

Document Type

Open Access Publication

DOI

10.1056/NEJMoa2303383

Rights and Permissions

Chen AP, Sharon E, O'Sullivan-Coyne G, Moore N, Foster JC, Hu JS, Van Tine BA, Conley AP, Read WL, Riedel RF, Burgess MA, Glod J, Davis EJ, Merriam P, Naqash AR, Fino KK, Miller BL, Wilsker DF, Begum A, Ferry-Galow KV, Deshpande HA, Schwartz GK, Ladle BH, Okuno SH, Beck JC, Chen JL, Takebe N, Fogli LK, Rosenberger CL, Parchment RE, Doroshow JH. Atezolizumab for Advanced Alveolar Soft Part Sarcoma. N Engl J Med. 2023 Sep 7;389(10):911-921. doi: 10.1056/NEJMoa2303383. Copyright © 2023 Massachusetts Medical Society. Reprinted with permission.

Recommended Citation

Chen, Alice P; Van Tine, Brian A; and et al., "Atezolizumab for advanced alveolar soft part sarcoma." New England Journal of Medicine. 389, 10. 911 - 921. (2023).
https://digitalcommons.wustl.edu/oa_4/3524

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.